Cardiothoracic & vascular anesthesia

The use of transcutaneous electrical acupoint stimulation to reduce opioid consumption in patients undergoing off-pump CABG: a randomized controlled trial

Perioper Med (Lond)Published Randomised controlled trial

Authors' conclusion

Transcutaneous electrical acupoint stimulation with distal-proximal acupoints combination, compared to regional acupoints combination and sham acupuncture, significantly reduced sufentanil consumption in patients who underwent off-pump coronary artery bypass grafting surgery.

Study context

Population
Patients undergoing off-pump CABG under GA313 completed
Participants
315 patients
Comparison
Transcutaneous electrical acupoint stimulation (TEAS) with distal-proximal or regional acupoints combination vs sham acupuncture, 30 min before anaesthesia induction
  • Sham acupuncturen = 105reference
  • Regional acupoints combinationn = 105
  • Distal-proximal acupoints combinationn = 105
Primary endpoint
Sufentanil dose during anaesthesia
Methodological detailsmulticentre, double-blind, sham-controlled
  • Multicentre
  • Double-blind
  • Sham-controlled

Primary result

As reported in the abstract

Mean difference

- 34.9 μg

CI - 64.9 to - 4.9P = 0.023

Distal-proximal vs Sham

Mean difference

- 35.5 μg

CI - 65.6 to - 5.5P = 0.020

Distal-proximal vs Regional

Distal-proximal

303.9

unspecified (as printed in parentheses) 10.8 · μg

Regional

339.5

Secondary outcomes

Secondary outcomes (vasoactive-inotropic score, propofol consumption, mechanical ventilation, cardiac care unit and postoperative hospital stay, complications, 30-day mortality)

Comparable among three groups

Original publication

The use of transcutaneous electrical acupoint stimulation to reduce opioid consumption in patients undergoing off-pump CABG: a randomized controlled trial. Perioper Med (Lond). Published 5 July 2024. doi:10.1186/s13741-024-00427-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.